Showing results (901-910 of 932) with videos related to
Sort By:
Pageof 94
The Pediatric Infectious Disease Journal|May 7, 2005
GB virus C infection in children with perinatal human immunodeficiency virus infectionSusan Schuval, Jane C Lindsey, Jack T Stapleton, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2012
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudyK E Schmader, M N Oxman, M J Levin, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2013
Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medicationsMichael R Irwin, Myron J Levin, Mark L Laudenslager, et al.Proceedings of the National Academy of Sciences of the United States of America|December 15, 2010
Chemical generation of bispecific antibodiesVenkata R Doppalapudi, Jie Huang, Dingguo Liu, et al.The Journal of Infectious Diseases|March 13, 2018
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or OlderAnthony L Cunningham, Thomas C Heineman, Himal Lal, et al.Clinical Drug Investigation|January 16, 2026
Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-studyAndrew Ustianowski, Myron J Levin, Stephane De Wit, et al.Journal of the American Geriatrics Society|April 20, 2010
Workshop on immunizations in older adults: identifying future research agendasKevin P High, Richard T D'Aquila, Rebecca A Fuldner, et al.Human Vaccines & Immunotherapeutics|June 20, 2019
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trialsLidia Oostvogels, Thomas C Heineman, Robert W Johnson, et al.The New England Journal of Medicine|April 20, 2022
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19Myron J Levin, Andrew Ustianowski, Stéphane De Wit, et al.Memorias Do Instituto Oswaldo Cruz|May 5, 1998
Towards the physical map of the Trypanosoma cruzi nuclear genome: construction of YAC and BAC libraries of the reference clone T. cruzi CL-BrenerI Ferrari, H Lorenzi, M R Santos, et al.Pageof 94